Health+Tech
Health+Tech
Ancilia Presentation and Q&A with CEO Alexandra Sakatos
Ancilia is a computational bio-platform company that engineers phage-resistant bacterial therapeutics utilizing CRISPR/Cas to treat microbiome-linked diseases including inflammatory bowel disease (IBD) and immunotherapy-associated colitis.
Continue Reading >
Health+Tech
The First Broad Spectrum Blood Test for Autism with BioROSA
Autism is the fastest growing neuro developmental disorder in the world, currently impacting 1 in 54 children in the U.S. and up to 3% of children worldwide.
Continue Reading >
Health+Tech, Investing
Bringing Science Fiction to Life
New advances in biomedical science are creating cures and health solutions that could have only been deemed science fiction a few years ago
Continue Reading >
Health+Tech
The Promise of Senolytics
The emerging field of senololytics explores the destruction of aged (senescent) cells, while sparing healthy ones to promote longevity
Continue Reading >
Health+Tech
Proteomics: Using Proteins to Track Disease and Fight Back
The emerging field of disease proteomics aims to identify proteins involved in disease, analyze how their expression, structure, and function causes illness, and generate novel insights into how we can fight back
Continue Reading >
Health+Tech
The Present and Future of Digital Therapeutics
Chronic disease incidence and treatment costs are escalating at an unsustainable pace. Digital therapeutics offers the opportunity to reverse this dangerous trend.
Continue Reading >
Health+Tech
The Future of Gene Therapy
Gene therapy has advanced greatly since its humble beginnings in 1990. New approaches are bringing bespoke cures for genetic diseases within reach.
Continue Reading >